Embla Medical hf. (OSSUY) Q3 2026 Earnings Call Transcript | EN590 Commodities

Market Analysis 2026-10-20T06:13:59-04:00

Embla Medical hf. (OSSUY) Q3 2026 Earnings Call October 20, 2026 3:00 AM EDT Sveinn Sölvason - President & CEOGudny Sveinsdottir - Chief Financial Officer Martin Brenoe - Nordea Markets, Research DivisionTobias Nissen - Danske Bank A/S, Research DivisionBeatrice Fairbairn - Joh. Berenberg, Gossler & Co. KG, Research DivisionTom RosenfeldYiwei Zhou - SEB, Research Division At this time, I would like to welcome everyone to this Embla Medical Q3 2026 Conference Call. [Operator Instructions] Today's call is being recorded. If you have any objections, please disconnect at this time. I would now like to introduce President and CEO, Sveinn Solvason; and CFO, Arna Sveinsdottir. Sveinn, please begin. Thank you very much, and good morning, everyone, and welcome to Embla Medical's Third Quarter 2026

About EN590 Commodities Group

25+ years in mineral exploration and extraction. 15+ years of global commodity trading. Based in New York, USA serving 75+ countries.

Join our Telegram channel: t.me/EN590

Visit our Blog